Connect with us
Information

WORLD EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

WORLD EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

otc:crtpf

POPULAR ARTICLES

Cardiol’s Pending Phase II/III COVID-19 Trial Medically Justified and Even More Timely

life science investing

Cardiol’s Pending Phase II/III COVID-19 Trial Medically Justified and Even More Timely

Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx(TM)

pharmaceutical investing

Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx(TM)

OTC:CRTPF

cannabis investing

Cardiol Therapeutics Announces Increase to Previously Announced Bought Deal Public Offering

LATEST ARTICLES

OTC:CRTPF

pharmaceutical investing

Cardiol Therapeutics Announces $11.25 Million Bought Deal Public Offering

OTC:CRTPF

cannabis investing

Cardiol Therapeutics Files International Patent Application Covering the Use of Cannabidiol (CBD) to Improve the Outcome of Patients with COVID-19

OTC:CRTPF

pharmaceutical investing

Cardiol Announces Study Demonstrating Its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart

OTC:CRTPF

cannabis investing

Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure

OTC:CRTPF

cannabis investing

Cardiol Therapeutics Announces Filing of 2019 Year-End Financial Statements and MD&A

OTC:CRTPF

cannabis investing

Cardiol Therapeutics Signs Supplier Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc.

OTC:CRTPF

cannabis investing

Cardiol Therapeutics Receives Health Canada Approval for Phase 1 Study of its Pharmaceutically Produced Cannabidiol (CBD) Formulation

OTC:CRTPF

cannabis investing

Cardiol Therapeutics’ Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada

OTC:CRTPF

cannabis investing

Cardiol Therapeutics Appoints Michael J. Willner, Esq. as Business Advisor

Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to Its Board of Directors

cannabis investing

Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to Its Board of Directors

Cardiol Therapeutics Comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement Agency

cannabis investing

Cardiol Therapeutics Comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement Agency

OTC:CRTPF

cannabis investing

Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx(TM) 100

Latest News

Homerun Resources Inc. Announces Receipt of a Competitive Budgetary Offer for Latin America's First Dedicated Solar Glass Manufacturing Facility

LaFleur Minerals Engages Bumigeme to Complete Valuation Report on Beacon Gold Mill

Sranan Gold Provides Progress Update on Drilling Campaign at the Tapanahony Gold Project in Suriname

Brunswick Exploration Has Now Identified Four Major New Dykes in 2025 at Mirage

Radisson Announces Positive Preliminary Economic Assessment for O'Brien Gold Project

Outlook Reports

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Triumph Gold

TIG:CA

Quimbaya Gold

QIM:CC

New Age Exploration

NAE:AU

Asara Resources

AS1:AU

International Lithium Corp.

ILC:CA

Syntheia

SYAI:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES